Abstract:After World War II, the Japanese pharmaceutical education system was drastically changed on the advice of the general headquarters of the American occupational army. Two universities and 18 colleges were reformed in to new universities. Graduates from pharmaceutical universities were eligible to take the national pharmacist's license examination, which was conducted by the Ministry of Health and Welfare. New pharmaceutical departments within a university could be founded provided that they conformed to stringent standards set by the Ministry of Education, covering such aspects as location, building facilities, equipment, teaching administration, number of teachers and qualifications, and curriculum. From 1949 to 1983, seven national, three public and 31 private universities with pharmaceutical departments were established. Three departments, pharmacy, manufacturing pharmacy, and biological pharmacy, are present in several pharmaceutical universities. The number of students attending university pharmaceutical departments increased from 4,000 in 1940 to 8,000 in 1983. In 1973, the Japan Pharmaceutical Association proposed a six-year pharmaceutical education system. However, the Council of Deans of in the faculty of pharmaceutical sciences at the national university and the Ministry of Education were opposed. The plans to reform pharmaceutical education were thrown into confusion from 1983 to 1990. The Six Members Council for pharmaceutical education (Rokushakon), the Ministry of Education, the Ministry of Welfare, the Japan Pharmaceutical Association, the Japan Hospital Pharmaceutical Association, the Council of Deans in the faculty of pharmaceutical sciences at the national university, and the Association of Private Pharmaceutical Universities was reformed in 1999, and then the council carried out debate into 2004. The Six Members Council arrived at an agreement that requires six years of pharmaceutical educations, including six months of the practical pharmacy expensece in a hospital pharmacy or health insurance pharmacy, in 2003. Finally in 2004, the laws for school education and the laws for becoming a pharmacist were amended in the House of Representatives and the House of Councilors. The authors expess their opinions about pharmaceutical education, pharmacists, and the pharmaceutical industry in the second decade of the 21st century.

Regulatory differences and similarities: Systems in Japan

An Empirical Analysis of Japan's Drug Development Lag Behind the United States

How Does “Regulatory Practice” Create Discrepancies in Drug Label Information Between Asian and Western Countries? Different Label Information for Direct Oral Anticoagulants Approved in the United States, Europe, Korea, and Japan

New Japanese Regulatory Frameworks for Post-Marketing Management of Pharmaceutical Products

Different Development Strategies Affecting Japan's Drug lag between Japan-Based and Foreign-Based Companies

Comparison of regulatory approval system for medicines in emergency among Japan, the United States, the United Kingdom, Europe, and China

Trend Analysis of Regulatory Approvals for Generics and Biosimilars in Japan: 15 Years of PMDA During Fiscal Years 2009–2023

Significant Differences in Drug Lag in Clinical Development Among Various Strategies Used for Regulatory Submissions in Japan

Regulatory approval pathways for anticancer drugs in Japan, the EU and the US

Paediatric Drug Development in Japan: Current Status and Future Challenges

Physicians' conflicts of interest in Japan and the United States: lessons for the United States

Strengthening the Competitiveness of Japan's Pharmaceutical Industry: Analysis of Country Differences in the Origin of New Drugs and Japan's Highly Productive Firm.

Influence of Expedited Programs in the United States on Oncology Drug Development in Japan

Draft Guideline for Industry to Manage Drug Shortages in Japan

Comparison of supportive regulatory measures for pediatric medical device development in Japan and the United States

[Verification for reform of the Japanese pharmaceutical education by some organizations in 60 years, after World War II]

[Present Conditions of Marijuana Regulation in USA: Medical and Recreational Use]

Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory Analysis

Safety Evaluation and Information Provision for Appropriate Drug Usage in Elderly Patients in Japan

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency

Trends in the market for drug delivery devices categorized as combination drugs and medical devices and regulatory challenges for autoinjectors in Japan